Insider Trading - NEXIEN BIOPHARMA Inc (NXEN)

Real time insider trading transaction history:

  1. Insiders must file a Form 4 covering their trades within two business days.
  2. Section 16 prohibits insiders from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period:
Insider Trading Transactions for NEXIEN BIOPHARMA Inc
Goto 0, 1, Next

Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2019-04-04
Sale
2019-05-01
7:15 pm
NEXIEN BIOPHARMA Inc NXEN Kanativa USA Inc.
10% Owner
5,000,000 $0.085 $425,000 19,000,000
(Direct)
View
2019-04-04
Sale
2019-05-01
7:56 pm
NEXIEN BIOPHARMA Inc NXEN Friedland Jeffrey
Former 10% Owner
5,000,000 $0.085 $425,000 20,062,133
(Indirect
Direct)
View
2019-04-04
Sale
2019-05-02
2:08 pm
NEXIEN BIOPHARMA Inc NXEN Kanativa Inc.
10% Owner
5,000,000 $0.085 $425,000 19,000,000
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2017-11-29
Other
2017-11-30
2:54 pm
2017-11-29
2018-01-31
Intiva BioPharma Inc. KDRH Friedland Jeffrey
CEO
10% Owner
16,550,599 $0 18,758,599
(Indirect)
View
2017-11-29
Other
2017-11-30
2:55 pm
N/A
N/A
Intiva BioPharma Inc. KDRH Intiva USA Inc
10% Owner
15,099,083 $0 39,099,083
(Direct)
View
2017-11-29
Other
2017-11-30
6:40 pm
N/A
N/A
Intiva BioPharma Inc. KDRH Greenberg Richard S
Chairman
10% Owner
15,602,386 $0 40,402,386
(Indirect)
View
2017-11-29
Other
2017-12-01
10:37 am
2017-11-29
2018-01-31
Intiva BioPharma Inc. KDRH Goldfarb Robert I
COO
651,427 $0 1,675,427
(Direct)
View
2018-01-16
Exercise
2018-02-23
3:31 pm
2017-11-29
2018-01-31
Intiva BioPharma Inc. NTVA Friedland Jeffrey
CEO
10% Owner
20,800 $0 26,270,400
(Indirect)
View
2018-01-16
Acquisition
2018-02-23
3:31 pm
N/A
N/A
Intiva BioPharma Inc. NTVA Friedland Jeffrey
CEO
10% Owner
20,800 $0.25 26,270,400
(Indirect)
View
2018-01-12
Exercise
2018-02-26
1:10 pm
2017-11-29
2018-01-31
Intiva BioPharma Inc. NTVA Bankier Alain D
Director
28,000 $0 2,284,000
(Direct)
View
2018-01-12
Acquisition
2018-02-26
1:10 pm
N/A
N/A
Intiva BioPharma Inc. NTVA Bankier Alain D
Director
28,000 $0.25 2,284,000
(Direct)
View
2018-01-12
Exercise
2018-02-26
2:53 pm
2017-11-29
2018-01-31
Intiva BioPharma Inc. NTVA Goldfarb Robert I
COO
2,400 $0 1,031,200
(Direct)
View
2018-01-12
Acquisition
2018-02-26
2:53 pm
N/A
N/A
Intiva BioPharma Inc. NTVA Goldfarb Robert I
COO
2,400 $0.25 1,031,200
(Direct)
View
2018-03-08
Disposition
2018-03-12
7:13 pm
N/A
N/A
Intiva BioPharma Inc. NTVA Friedland Jeffrey
10% Owner
1,166,667 $0 25,103,733
(Direct)
View
2018-05-05
Exercise
2018-05-22
5:30 pm
2017-11-29
2018-06-07
Intiva BioPharma Inc. NTVA Goldfarb Robert I
COO
2,400 $0 1,031,200
(Direct)
View
2018-05-05
Exercise
2018-05-22
5:30 pm
N/A
N/A
Intiva BioPharma Inc. NTVA Goldfarb Robert I
COO
2,400 $0.38 1,031,200
(Direct)
View
2018-05-15
Exercise
2018-05-23
10:51 am
2017-11-29
2018-06-07
Intiva BioPharma Inc. NTVA Bankier Alain D
CEO
28,000 $0 2,284,000
(Direct)
View
2018-05-15
Exercise
2018-05-23
10:51 am
N/A
N/A
Intiva BioPharma Inc. NTVA Bankier Alain D
CEO
28,000 $0.38 2,284,000
(Direct)
View
2018-06-19
Exercise
2018-06-29
12:14 pm
2017-11-29
2018-06-29
Intiva BioPharma Inc. NTVA Snider Lindy
Director
40,000 $0 520,000
(Direct)
View
2018-06-19
Exercise
2018-06-29
12:14 pm
N/A
N/A
Intiva BioPharma Inc. NTVA Snider Lindy
Director
40,000 $0.38 520,000
(Direct)
View
2018-06-27
Exercise
2018-06-29
12:43 pm
2017-11-29
2018-06-29
Intiva BioPharma Inc. NTVA Greenberg Richard S
Chairman
10% Owner
88,000 $0 24,976,000
(Direct)
View
2018-06-27
Other
2018-06-29
12:43 pm
2017-11-29
2018-06-29
Intiva BioPharma Inc. NTVA Greenberg Richard S
Chairman
10% Owner
88,000 $0 24,976,000
(Direct)
View
2018-06-27
Exercise
2018-06-29
12:43 pm
N/A
N/A
Intiva BioPharma Inc. NTVA Greenberg Richard S
Chairman
10% Owner
88,000 $0.38 24,976,000
(Direct)
View
2018-06-27(A)
Exercise
2018-07-02
5:45 pm
2017-11-29
2018-06-29
Intiva BioPharma Inc. NTVA Greenberg Richard S
Chairman
10% Owner
88,000 $0 976,000
(Direct)
View
2018-06-27(A)
Other
2018-07-02
5:45 pm
2017-11-29
2018-06-29
Intiva BioPharma Inc. NTVA Greenberg Richard S
Chairman
10% Owner
88,000 $0 976,000
(Direct)
View
2018-06-27(A)
Exercise
2018-07-02
5:45 pm
N/A
N/A
Intiva BioPharma Inc. NTVA Greenberg Richard S
Chairman
10% Owner
88,000 $0.38 976,000
(Direct)
View
2018-07-25
Option Award
2018-07-26
11:28 am
2018-07-25
2025-07-25
Intiva BioPharma Inc. NTVA Greenberg Richard S
Chairman
10% Owner
150,000 $0 1,038,000
(Direct)
View
2018-07-25
Option Award
2018-07-26
11:38 am
2018-07-25
2025-07-25
Intiva BioPharma Inc. NTVA Bankier Alain D
CEO
940,000 $0 3,224,000
(Direct)
View
2018-07-25
Option Award
2018-07-26
3:27 pm
2018-07-25
2025-07-25
Intiva BioPharma Inc. NTVA Wasoff Evan L
CFO
420,000 $0 1,420,000
(Direct)
View
2018-07-25
Option Award
2018-07-27
1:41 pm
2018-07-25
2025-07-25
Intiva BioPharma Inc. NTVA Snider Lindy
Director
100,000 $0 580,000
(Direct)
View
2018-08-08
Other
2018-09-04
4:48 pm
2017-11-29
2018-08-08
Intiva BioPharma Inc. NTVA Goldfarb Robert I
COO
4,800 $0 1,031,200
(Direct)
View
2018-08-08
Other
2018-09-04
5:04 pm
2017-11-29
2018-08-08
Intiva BioPharma Inc. NTVA Snider Lindy
Director
80,000 $0 620,000
(Direct)
View
2018-08-06
Other
2018-09-05
12:27 pm
2017-11-29
2018-08-08
Intiva BioPharma Inc. NTVA Bankier Alain D
CEO
56,000 $0 3,224,000
(Direct)
View
2018-10-26
Option Award
2018-10-29
3:04 pm
2018-10-26
2025-10-26
NEXIEN BIOPHARMA Inc NXEN Greenberg Richard S
VP
100,000 $0 1,138,000
(Direct)
View
2018-10-01
Option Award
2018-10-29
6:35 pm
2018-10-01
2025-10-01
NEXIEN BIOPHARMA Inc NXEN Bankier Alain D
Chairman
1,000,000 $0 4,224,000
(Direct)
View
2018-10-26
Option Award
2018-10-30
1:59 pm
2018-10-26
2025-10-26
NEXIEN BIOPHARMA Inc NXEN Wasoff Evan L
CFO
200,000 $0 1,620,000
(Direct)
View
2019-11-22
Gift
2019-11-25
2:07 pm
N/A
N/A
NEXIEN BIOPHARMA Inc NXEN Friedland Jeffrey
Former 10% Owner
1,062,133 $0 19,000,000
(Direct)
View
2020-08-12
Conversion
2020-08-14
5:33 pm
N/A
N/A
NEXIEN BIOPHARMA Inc NXEN Greenberg Richard S
CEO
1,800,880 $0.014 2,938,880
(Direct)
View
2020-08-19
Option Award
2020-08-21
1:15 pm
2020-08-19
2027-08-19
NEXIEN BIOPHARMA Inc NXEN Goldfarb Robert I
COO
1,000,000 $0 2,028,800
(Direct)
View
2020-08-19
Option Award
2020-08-21
1:16 pm
2020-08-19
2027-08-19
NEXIEN BIOPHARMA Inc NXEN Wasoff Evan L
CFO
1,500,000 $0 3,120,000
(Direct)
View
2020-08-19
Option Award
2020-08-21
1:17 pm
2020-08-19
2027-08-19
NEXIEN BIOPHARMA Inc NXEN Greenberg Richard S
CEO
2,500,000 $0 5,708,880
(Direct)
View
2020-08-12(A)
Conversion
2020-08-25
5:19 pm
N/A
N/A
NEXIEN BIOPHARMA Inc KDRH Greenberg Richard S
CEO
1,797,192 $0.014 5,435,192
(Direct)
View
2020-11-24
Option Award
2020-11-30
3:58 pm
2020-11-24
2023-11-24
NEXIEN BIOPHARMA Inc NXEN Greenberg Richard S
CEO
10% Owner
3,228,859 $0 8,664,051
(Direct)
View
2021-04-01
Option Award
2021-04-05
5:33 pm
N/A
N/A
NEXIEN BIOPHARMA Inc NXEN Greenberg Richard S
CEO
10% Owner
1,000,000 $0 9,664,051
(Direct)
View
2021-04-01
Option Award
2021-04-05
5:34 pm
N/A
N/A
NEXIEN BIOPHARMA Inc NXEN Wasoff Evan L
CFO
1,000,000 $0 4,120,000
(Direct)
View
2021-06-07
Option Award
2021-06-07
6:00 pm
N/A
N/A
NEXIEN BIOPHARMA Inc NXEN Snider Lindy
Director
250,000 $0 830,000
(Direct)
View
2021-11-29
Option Award
2021-11-29
12:20 pm
N/A
N/A
NEXIEN BIOPHARMA Inc NXEN Wasoff Evan L
CFO
500,000 $0 4,620,000
(Direct)
View
2021-11-29
Option Award
2021-11-29
12:23 pm
N/A
N/A
NEXIEN BIOPHARMA Inc NXEN Greenberg Richard S
CEO
10% Owner
500,000 $0 10,164,051
(Direct)
View
(A) Indicate amendment filing.
Goto 0, 1, Next